Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from vaccination and racial inequities in access to health, to cancer care, obesity and mental health.
Since joining NPR in 2008, Noguchi has also covered a range of business and economic news, with a special focus on the workplace — anything that affects how and why we work. In recent years, she has covered the rise of the contract workforce, the #MeToo movement, the Great Recession and the subprime housing crisis. In 2011, she covered the earthquake and tsunami in her parents' native Japan. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award and received First Place and Best In Show in the radio category from the National Headliner Awards. She also loves featuring offbeat topics, and has eaten insects in service of journalism.
Noguchi started her career as a reporter, then an editor, for The Washington Post.
Noguchi grew up in St. Louis, inflicts her cooking on her two boys and has a degree in history from Yale.
-
For some people, getting a positive coronavirus test could mean loss of income or other life disruptions. Doctors worry about growing disincentives to test and how this could prolong the pandemic. -
Amid a surge in omicron cases and hospitalizations, public health leaders are grappling with how to get a tuned-out public to pay attention. Experts urge communicators to cut through the noise.
-
As COVID cases surge, many Americans are tuning out the pandemic. Public health messages and guidance are running into widespread indifference and disengagement.
-
Rapid tests for COVID-19 are proving difficult to find both for local governments and individuals. The Biden administration says relief is on the way. But what's behind the supply challenges?
-
A ban on using telemedicine to prescribe controlled medications was suspended in the pandemic. That's allowed many to seek opioid addiction treatment, but some worry about potential for abuse. -
Many public health experts are pushing for stronger measures than the Biden administration and governors are willing to take to reduce impacts from the growing omicron wave. Why the disconnect?
-
The Biden administration's moves to increase the availability of at-home COVID tests may help refill store shelves. There are concerns about the ability to supply and carry out other forms of testing.
-
The run on at-home COVID tests highlights some of the country's desperation in getting critical testing capacity up to speed. There are potentially some other roadblocks with other forms of testing.
-
With a fast-growing winter surge upon us, self-testing kits remain expensive and hard to find. The reasons go back to the approach the U.S. took from the outset in developing tests. -
By 2022, the vast majority of employers had plans to start returning remote workers to the offices. Omicron changed that, and it may also make vaccine mandates more likely and more popular.
